CRDF, ATER and LEXX among pre market gainers

Energy Focus (EFOI) +52% launches nUVo virus-targeted UVC air disinfectors to public.
Lexaria Bioscience (LEXX) +25% dehydraTECHTM-CBD reduces arterial stiffness, results confirmed in human clinical study HYPER-H21-2.
Dare Bioscience (DARE) +23% announces FDA approval of XACIATO™ (clindamycin phosphate) vaginal gel as a treatment for bacterial vaginosis.
Auddia (AUUD) +21% announces partnership between Vodacast and Bleav podcasting network.
RLX Technology (RLX) +9% announces $500 million share buyback plan.
PagerDuty (PD) +10% after Q3 tops estimates, upside outlook.
EPAM Systems (EPAM) +9% on move to S&P 500.
Paysafe Limited (PSFE) +8% leadership and directors purchase $2.8M in common shares.
Virpax Pharmaceuticals (VRPX) +7% reports successful results of toxicology and pharmacokinetic study for epoladerm.
Scopus BioPharma (SCPS) +6%.
Cardiff Oncology (CRDF) +7%.
Kaival Brands Innovations (KAVL) +7%.
Olema Pharmaceuticals (OLMA) +7%.
Weber (WEBR) +7% on FQ4 results.
Aterian (ATER) +6%.
The Lovesac (LOVE) +6% on Q3 results.
Dave & Buster's Entertainment (PLAY) +6% on Q3 results.
The Goodyear Tire & Rubber (GT) +5% is called an under the radar EV winner by Deutsche Bank.